Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Anardana (Punica granatum dried seeds) delivers potent antioxidant and anti-inflammatory effects through ellagic acid and polyphenols that modulate SOD, GSH, and catalase pathways. Research demonstrates its seed oil prevents 90% of MCF-7 breast cancer cell proliferation while containing steroidal estrogens that exhibit measurable estrogenic activity.
Reported Benefits (Provisional)
Origin & History
Anardana, derived from the dried seeds of Punica granatum, is a tangy, antioxidant-rich superfood native to the Middle East and South Asia, particularly Iran and India. These nutrient-dense seeds are valued in functional nutrition for their significant digestive benefits, cardiovascular support, and broad spectrum of bioactive compounds.
Research Narrative (Provisional)
Research indicates Anardana's significant antioxidant, anti-inflammatory, and digestive-enhancing properties. Studies support its role in promoting cardiovascular health, aiding digestion, and mitigating systemic inflammation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber - Vitamin C - Potassium - Ellagic Acid - Polyphenols (e.g., anthocyanins, tannins)
Reported Mechanism (Provisional)
Anardana's bioactive compounds modulate cellular antioxidant systems by enhancing superoxide dismutase (SOD), glutathione (GSH), and catalase enzyme activity. Ellagic acid and polyphenols reduce inflammatory markers while increasing reactive oxygen species (ROS) and malondialdehyde (MDA) levels in cancer cells, inducing cell cycle arrest at G0/G1 and S phases. The steroidal estrogens present demonstrate direct estrogenic activity through estrogen receptor binding pathways.
Clinical Narrative (Provisional)
Current evidence derives primarily from in vitro and animal studies, with no specific human clinical trials on Anardana available. Laboratory research shows pomegranate seed oil (PSO) pretreatment at 50-200 μg/mL increased H9c2 cell viability from 60% to 88% in a dose-dependent manner (p < 0.001). Animal studies using nano-PSO at 150 μL/day over 5 doses demonstrated delayed prion disease progression in mice with no acute toxicity markers. Human clinical trials are urgently needed to validate these promising preclinical findings.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.